We assessed the prognostic signifi cance of infections in relation to current prognostic scores and explored if infection could be considered per se a distinct clinical stage in the natural history of cirrhosis.
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It is well established that bacterial infections are common in patients with cirrhosis and carry a poor prognosis ( 1 ) . More worryingly, the prevalence of infections by multi-resistant bacteria is also increasing ( 2 ) . Recently, the role of infections in changing the natural history of patients with cirrhosis has been hypothesized, and the occurrence of infection in patients with cirrhosis has been proposed as a separate clinical stage, based on a meta-analysis of 178 studies ( 3 ) .
Among patients with cirrhosis on the transplant waiting list, prioritization is based on predictive scores based primarily on liver disease severity. Th e relative shortage of organ donors renders allocation algorithms of organs essential, and the optimal strategy based on scoring systems or waiting time is still under debate.
Th e Model for End Stage Liver Disease (MELD) score incorporates serum creatinine, serum total bilirubin and INR and is widely used to predict the short-term mortality in patients with cirrhosis ( 4 ) . Many studies have shown its capability to correctly rank potential liver recipients according to their severity of liver disease and mortality risk, however, potential limitations of this score have been reported ( 5, 6 ) . Despite their widespread application, the prognostic accuracy of all these models is far from being satisfactory and a large number of patients still die while on the
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Elena Dionigi , MD 1 , 2 transplant waiting list, and sometimes with MELD scores below the threshold of transplantation.
D' Amico recently proposed a sub-classifi cation of cirrhosis based on clinical stages with distinct one-year mortality that ranges from 1-57% depending on the stage ( 7 ) . Th is classifi cation is simple and reproducible, defi ned by clinical criteria that occur in the natural history of cirrhosis such as presence of varices, ascites and variceal bleeding and have a diff erent prognosis. Infection was proposed as a further stage in this classifi cation ( 3 ) .
Th e aim of this study was twofold, fi rstly to confi rm the prognostic importance of documented bacterial infections in patients with cirrhosis and secondly to assess the prognostic signifi cance of infection in relation to current prognostic scores and ascertain if infection could be considered per se a distinct clinical stage in the natural history of cirrhosis in a well-defi ned cohort of consecutive hospitalized patients.
METHODS
We evaluated retrospectively all patients with cirrhosis consecutively admitted to the Hepatology ward of a tertiary referral liver center over a 2-year period, from 1 January 2007 to 31 December 2008. Inclusion criteria were diagnosis of cirrhosis based on history, clinical, histological, biochemical and imaging features. We excluded patients with a hospital stay of less than 48 h, patients with human immunodefi ciency virus (HIV) infection or concomitant myeloproliferative disease, patients with HCC outside the Milan criteria and those with previous liver transplantation (OLT). We followed-up patients until OLT or death and the latest follow-up data were collected in 31 October 2009 using the national health system-integrated hospital register.
Th e following variables were collected from hospital and laboratory based information systems: sex, age, and etiology of cirrhosis; severity of liver disease, components of MELD and United Kingdom Model for End-stage Liver Disease (UKELD). We evaluated blood test results on admission and during hospitalization. Bacterial cultures of blood, urine, peritoneal and pleural fl uid were performed whenever infection was suspected based on clinical and/or laboratory signs, and all positive cultures were recorded. Patients with ascites or pleural eff usion had a diagnostic tap performed for cell count and cultures when appropriate. According to the etiology of cirrhosis, the patients were classifi ed into three groups: viral hepatitis (HBV and HCV), alcohol, and all other etiologies.
According to international criteria, diagnosis of infection was based on the following: Spontaneous bacterial peritonitis or spontaneous empyema (SBP and SE) were defi ned as a neutrophil cell count in ascitic and pleural fl uid ≥250/mm 3 , respectively, or positive culture ( 8 ) . A clean-catch midstream urine specimen for culture and chemical analysis was collected, when urinary tract infection (UTI) was suspected, and UTI was diagnosed as follow: (a) urine leukocyte count ≥10 cells/mm 3 and positive urine culture, (b) fever, pyuria (≥10 leukocytes/mm 3 ) and ≥100,000 CFU/ml, or (c) uncountable leukocytes without positive culture ( 9 ) . In patients with documented or suspected pneumonia, bronchial secretions were collected as appropriate; in case of negative cultures, pneumonia was diagnosed if there was radiological evidence of pulmonary infi ltration combined with at least two of the following criteria: fever >38 °C or hypothermia <35.5 °C, dyspnea, cough, and purulent sputum, pleural chest pain, or signs of consolidation on physical examination. Other body fl uids, like bile, and swabs were cultured when an infection was clinically suspected and infections were diagnosed according to clinical, radiological, and microbiologic data following standard criteria ( 10 ) . Screening swabs for MRSA were not evaluated unless a clinically relevant (bloodstream or wound) MRSA infection was diagnosed. Infections were considered community acquired (CA) when diagnosed at admission or developed within 48 h aft er hospitalization and nosocomial when the diagnosis was made thereaft er ( 11 ) . Healthcare associated (HCA) infections were not defi ned, as this study was planned before this classifi cation was routinely used in Hepatology practice ( 12, 13 ) .
Statistical analysis
Categorical variables are presented as number and percentage, while quantitative variables are summarized by mean and s.d. if the distribution is normal or median and interquantile range if not.
Th e end point was death. Th e follow-up periods began with fi rst admission and ended with death or liver transplantation, censoring the remaining patients at the last follow-up contact at the hospital or with their general practitioner. Th e latter were contacted for such information. In the fi rst instance, Cox regression analysis was performed and patients who were transplanted were censored as alive at the time of transplantation. We also used competing risk Cox regression analysis, with death and liver transplantation considered as competing risks. In order to minimize the probability of selection bias, we repeated the analysis in a cohort of infected and non-infected propensity score matched patients.
Mortality rate/100 person/year was calculated and survival was described with the Kaplan-Meier method. Uni-and multivariate Cox regression and competing risk Cox regression models were fi tted to identify the most important predictors of outcome. Variables with P <0.1 at univariate analysis were checked for collinearity and entered in the multivariate model, using a stepwise forward approach. Each patient was considered once in the analysis irrespective of the number of hospital admissions. Among patients with more than one hospital admissions, the date of fi rst admission was analyzed for patients without infection, whereas for patients with infection we considered the admission with the fi rst diagnosis of infection. In order to address immortal time bias, additional analyses were performed by classifying the infection event as a categorical time-dependent covariate in Cox survival models ( 14 ) .
We carried out a propensity analysis using logistic regression to create a score for the infected and non-infected patients. Th is model included MELD, hepatocellular carcinoma, patients transplanted, reasons of admission (acute decompensation or infection vs. others) as well as the interaction term with P ≤0.10 (MELD×reasons of admission). We used nearest-neighbor matching method with no replacement to match patients in the non-infected group with those in the infected group, with a calliper width of 0.2 of the standard deviation of the logit of the propensity score. Aft er matching appropriate non-parametric paired tests were used (Wilcoxon signed-rank test for continuous variables and McNemar test for dichotomous variables).
All analyses were performed using SPSS version 22.0 for Windows (IBM, New York), except from the competing risk analyses, which were performed using Stata version 12.1 (Statacorp, College Station, TX).
RESULTS

Patients
Over the study period, 501 patients with cirrhosis were consecutively admitted to our hospital for more than 48 h. Of these, 84 patients underwent OLT (18 in the infected group) and were censored as alive at the time of the transplant for the traditional survival analysis, while there was no follow-up information beyond admission for 14 (8 in the non-infected and 6 in the infected group). Patients on the liver-transplant list and patients with HCC were equally distributed among infected and non-infected patients. Further admissions occurred in 280 patients during the study period (153 patients had 2, 127 patients had 3 or more admissions) for a total of 781 diff erent hospital admissions. Mean follow-up was 12.7 (s.d. 10.4) months.
Th ere were 317 males and 184 females, with a mean age of 53.3 (s.d. 12.3). Most patients had severe liver disease (85% MELD>10 and 56% >15, while 80.5% were Child-Pugh score B or C); mean admission MELD was 17.1 (s.d. 6.9) and UKELD was 55.6 (s.d. 6.4). Th e etiology of cirrhosis was alcohol in 242 (48.3%), viral (HBV or HCV-related) in 114 (22.8%), and non viral-non alcohol in 145 (28.9%) cases, including 32 patients with cryptogenic cirrhosis and 15 with NASH. Forty-four patients had HCC and their distribution was even in the infected and non-infected groups. Table 1 shows main clinical characteristics and laboratory fi ndings at admission of the total cohort, in infected and non-infected patients. Th e characteristics of propensity score matched infected and non-infected patients are shown in the Supplementary Appendix . Th e mean MELD score of patients with infection at discharge did not signifi cantly diff er from their MELD score at admission (19.7±9.1 vs. 18.7±7.3, P =0.35) and was stable in 35% of the infected patients, improved in 32% and deteriorated in 33%.
Patients were hospitalized on account of decompensation of liver disease in 59.1% of cases, particularly for tense ascites (17.6% of cases), active gastrointestinal bleeding (18.6%), hepatic encephalopathy (9.4%) or jaundice (13.6%). Presence of overt infection accounted for 10.4% of the reasons of admission and elective procedures such as TIPS assessment and placement, loco-regional therapies for hepatocellular carcinoma (HCC), pre-transplant work-up or clinical reason not related with decompensation of liver disease for the remaining 30.5% of cases.
Hospital stay and prevalence of infection
Median length of in-hospital stay was 10 days (interquartile range 12.0), with a signifi cant diff erence between infected and noninfected patients (25.1 vs. 10.2 days; P <0.001). 49 patients were transferred from the ward to ITU and stayed there for a median of 7 days (interquartile range 10).
On a total of 781 admissions in 501 diff erent patients, the prevalence of infection was 25.6% ( n =200). In total, 60% ( n =120) of infections were CA (in 54 cases infection was already overt at admission, the remaining developed symptoms within 48 h) and 40% ( n =80) were nosocomial infections. Th ere were two patients 
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with bacterascites who were not treated with antibiotics and were considered as non-infected patients. In 52 patients, there were no positive cultures and diagnosis was based on a combination of clinical, biochemical and radiological criteria: 9 cases of pneumonia, 14 of SBP, 1 of UTI and 27 cases with other sites of infections (biliary source, soft tissues). Bacterial isolation was more prevalent in nosocomial than CA infections (98.8 vs. 57.5%; P <0.001).
Etiology and predictors of infection
Characteristics and factors associated with the presence of infection were evaluated on the total of 781 admissions. 148/200 (74.4%) infection cases were culture-positive bacterial infections; in some cases, multiple sites or multiple bacteria where isolated in the same patients for a total of 259 positive cultures. Th e majority of positive cultures involved gram-positive cocci (58.1%). Th e most common sites of bacterial isolation were blood, ascitic fl uid and urine with 73 (28.2%), 71 (27.4%), and 37 (14.3%) positive cultures respectively. Prevalence of multi-resistant strains was 23.1%, and there was no diff erence among community-acquired and hospital-acquired infections (20.2% ( n =24) vs. 27.5% ( n =22); P 0.236). Methicillin-resistant Staphylococcus Aureus, MRSA ( n =22), was the most frequently isolated multi-resistant strain, followed by Extended Spectrum β -Lactamase, ESBL ( N =20), gram negative multiresistant bacteria such as Pseudomonas aeruginosa, citrobacter freundii, serratia marcescens and stenotrophomonas maltophilia ( n =5), acinetobacter baumanni ( n =3) and vancomycin resistant enterococcus ( n =2). A summary of the principal characteristics of infections and cultures is presented in Table 2 . Factors associated with infection are presented in the Supplementary Appendix .
Outcomes
Analysis of outcomes was conducted considering only one admission per patient, either the fi rst or the one with a diagnosis of infection.
190 patients died from the date of fi rst admission, of which 52 died in-hospital, in a mean follow-up of 12.7 (s.d. 10.4) months.
In-hospital mortality rate was higher in those patients who presented with infection and/or developed infection during hospitalization (hazards ratio (HR) 5.02; 95% confi dence interval (CI): 2.75-9.16; P <0.001). Also, mortality was higher in this group even for patients who were discharged from hospital (HR 1.59; 95% CI: 1.12-2.25; P 0.009) and it remained so aft er excluding early deaths ( n =44), i.e., deaths that occurred <30 days from admission (HR 1.78; 95% CI: 1.28-2.49; P =0.001).
Variables which were signifi cantly associated with both 30 days ( Supplementary Appendix ) and overall mortality ( Table 3 ) according to univariate analyses were diagnosis of infection, reason of admission acute decompensation of liver disease or infection, more severe disease (UKELD, MELD, and Child-Pugh score non-A), ITU stay, advanced age and longer hospital admissions.
Mean survival of patients who were diagnosed with infection during hospitalization was 16.8 months, compared to 25.5 months of patients who didn't have an infection (HR 2.14; 95% CI: 1.61-2.85; P <0.001). Th ere was no signifi cant diff erence between mortality in patients with resistant bacteria infections ( n =24/34) compared with non-resistant infections ( n =63/126), with a mean survival of 12.2 vs. 18.1 months respectively (HR: 1.53; 95% CI: 0.95-2.44; P 0.077). Furthermore, no diff erence in survival between patients with CA and HA infections was seen ( P =0.48).
Variables signifi cant at univariate analysis were entered into logistic regression models to assess their relationship with the end-point. As before, due to co-linearity UKELD and reason of admission were not included in the model. Of the 118 patients who were admitted for reasons other than acute decompensation or infection, 21 developed an infection. Infection was signifi cantly associated with overall mortality in this subgroup (HR 1.381, 95% CI 1.178-1.618). Variables independently associated with higher 30-day mortality rate were the presence of infection at admission and/or during hospitalization (odds ratio (OR) 2.91; 95% CI: 1.48-5.70; P 0.002), MELD score (OR 1.11; 95% CI: 1.07-1.15; P <0.0001), ITU stay (OR 2.76; 95% CI: 1.42-5.34; P 0.003) and repeated admissions (OR 2.27; 95% CI: 0.99-5.24; P 0.054; see Supplementary Appendix ).
Variables independently associated with higher overall mortality rate were the diagnosis of bacterial infection (HR 1.79; 95% CI: 1.33-2.41; P <0.001), MELD score (HR 1.09; 95% CI: 1.07-1.11; P <0.001), ITU stay (HR 1.67; 95% CI: 1.10-2.53; P 0.017) and age (HR 1.03; 95% CI: 1.02-1.04; P <0.001). All the above is summarized in Table 3 . Th e same predictors of mortality were significant when competing risk analysis was used in the whole cohort ( Table 3 ), in propensity score matched infected and non-infected patients ( Table 4 ) and when immortal time bias was taken into account for patients who developed an infection aft er their fi rst admission ( Supplementary Appendix ). Survival rate at 3, 6, 12, and 30 months was 92, 87, 79 and 66% in those with MELD<15 and 67%, 61%, 57%, 45% in those with MELD ≥15.
Survival was worse in patients with bacteremia/SBP/pneumonia (14.2 months) compared to patients with other infections (20.8 months).
Figures show the Kaplan-Meier survival curves in patients with and without diagnosis of infection ( Figure 1 ) and stratifi ed by MELD<or ≥15 and diagnosis of infection ( Figure 2 ) .
In all stages of disease, mean survival was signifi cantly lower in infected vs. non-infected patients (log rank test for all analyses). In particular in patients with MELD<15, mean survival was 19.0 (15.3-22.8) vs. 27.1 (25.1-29.1) months, in those with and without When multivariate analysis was repeated excluding early deaths i.e., only including patients who survived at least 30 days aft er the episode of infection, MELD, history of infection and age were independent predictors of mortality ( Table 5 ). Predictors of survival did not change when competing risk analysis was performed in the whole cohort ( Table 5 ), in propensity score matched infected and non-infected patients ( Supplementary Appendix ) and when immortal time bias was taken into account for patients who developed an infection aft er their fi rst admission ( Supplementary Appendix ).
Survival rates at 3, 6, 12, and 30 months were 83%, 75%, 68%, and 59% in patients without diagnosis of infection, vs. 55%, 51%, 45%, and 39% in patients with diagnosis of infection. 
DISCUSSION
In this study, we have shown for the fi rst time that patients with cirrhosis who become infected have a greater risk of death even if they survive the acute episode of infection, independently of the severity of their underlying liver disease. We have further provided updated data on the prevalence and microbiology of bacterial infections in this setting.
We have included consecutive patients over a 2-year period and have followed them up for a median time of over 1 year. We have employed strict criteria to defi ne bacterial infection in order to obtain robust data on the infl uence of infection. Our fi ndings are striking in the sense that a single episode of infection was independently associated with survival over and above the scores used in transplant centers and degree of liver disease severity. Indeed, the occurrence of bacterial infection for a similar MELD score confers a very diff erent prognosis, and in all stages of disease survival was signifi cantly lower in infected patients than non-infected. Importantly patients with MELD scores <15 and infection, have a mortality rate very similar to those with MELD score ≥15 and no infection. Even when patients who did not survive the acute episode of infection were censored, an anamnestic history of infection still represented an independent predictor of survival. Deaths that occurred in less than 30 days from admission. Second, bacterial translocation from the intestine increases susceptibility to infection and becomes clinically signifi cant when it results in SBP and/or bacteraemia. Infection may lead to a systemic infl ammatory response syndrome and sepsis, further deteriorating the circulatory disturbance in cirrhosis, and increasing the risk to develop renal failure, encephalopathy and death. Infection, even aft er the resolution of an acute episode, may maintain increased levels of endotoxins, bile acids, nitric oxide, carbon monoxide, and cytokines such as tumor necrosis factor and interleukin- 6 ( refs 1,19 ) . Indeed, the levels of these pro-infl ammatory mediators may not return to baseline aft er resolution of the actual infection thus promoting a cascade of events that culminates in liver failure. Alternative or additional reasons have been proposed to explain the high mortality consequent to bacterial infections in cirrhosis, such as a cytokine-mediated septic cardiomyopathy ( 20 ) and the adrenal dysfunction that accompany the liver disease ( 21 ) . It is also possible that an anamnestic infective episode further worsens or induces immune-paresis and macrophage and neutrophil dysfunction, thus worsening survival ( 22 ) . In this study, we confi rmed the high prevalence of infections (26.2%) in hospitalized patients with cirrhosis as reported by other studies ( 2, 12, (23) (24) (25) , and also that bacterial infections worsen the prognosis of hospitalized patients with cirrhosis thus increasing mortality. We have also provided data beyond 30-day mortality Th ese results obtained in a strictly defi ned cohort of patients confi rm the previous fi ndings of our meta-analysis of 178 studies showing that infections increase mortality in cirrhosis fourfold, with 30% of patients dying within one month aft er infection and 30% dying within 1 year ( 3 ). Th is meta-analysis included cohorts with diff erent defi nitions of infection and varying disease severity, therefore important questions were left unanswered. Most importantly, we could not ascertain if patients with cirrhosis who get infected have a greater risk of death, or if patients with cirrhosis at risk of death get infections in the process of dying. Data from this study point towards the fi rst answer and suggest that infection alters the natural history of cirrhosis and confers a higher risk of death. Th is eff ect is independent of the Child-Pugh or the MELD score and was recently described in a cohort of patients with compensated cirrhosis due to viral hepatitis ( 15 ) . Th erefore, infection should be regarded as a separate stage of cirrhosis and possibly be added to the list of decompensating events, similar to ascites and variceal bleeding as was previously suggested ( 3, 16, 17 ) .
Th e cause of a high prevalence of infections in patients with cirrhosis is double: fi rst, patients with advanced chronic liver disease have severe disturbances in the defense mechanisms against bacterial infections (a depressed function of the reticuloendothelial system, neutrophil dysfunction, reduced serum complement and low bactericidal opsonin activity, monocyte deactivation) ( 18 ). 
LIVER
Bacterial Infections Change Natural History of Cirrhosis that has been usually provided in such studies ( 23, 26 ) . It should be noted that the prevalence of infections has not decreased over the past 15 years, despite a more advanced knowledge of the responsible mechanisms and the possibility for an early diagnosis. On the contrary, infections caused by multidrug resistant bacteria (MDRB) are increasing, and can lead to worse outcome ( 2 ) . Indeed, the prevalence of this type of infection was over 20% in our cohort; although we did not show a statistically diff erence in mortality between MDRB and non-MDRB infections, this is probably due to a type I error as the mean survival diff erence was 5 months in these groups. Th ese fi ndings have important clinical implications. For patients on the transplant-waiting list, organ allocation systems using minimal listing criteria may disadvantage patients with recent bacterial infections but lower MELD or UKELD scores. Indeed, although such scores allow for the allocation of organs to patients in greatest need, as they are reliable measures of mortality risk in patients with end-stage liver disease, they do not take into account a history of complications including infection and may not accurately refl ect the adverse impact of bacterial infection on survival in patients with cirrhosis.
In accord with the hypothesis that occurrence of bacterial infection represents a further prognostic stage, our study confi rms that mortality in a large population of patients with cirrhosis is strongly increased by any type of bacterial infection, regardless of the severity of liver disease. Th e development of infection therefore is independent of the clinical classifi cation of cirrhosis and likely depends on individual factors, such as genetic predisposition, intestinal permeability, bacterial translocation and immune activation. Along these lines, the development of biomarkers of susceptibility to infection will help to identify patients at risk and intervene at an earlier stage. Indeed, an earlier recognition and treatment of infection may be of great value to reduce mortality in these patients. Furthermore, new studies of primary and secondary prevention of infections beyond SBP are needed to improve outcomes, similar to the seminal ones for SBP ( 18 ) .
Th e main limitation of this study is its retrospective design, although we did include consecutive patients and we were able to obtain all required data from the patients' notes based on a predetermined protocol. Furthermore, we performed a subanalysis on propensity score-matched infected and non-infected patients. Our study cohort cosists of patients hospitalized in 2007-2008, therefore is not contemporary. However, there have been no major changes in the standard of care of decompensated patients since then and the magnitude of the eff ect of infections in survival is such that the results are pertinent for contemporary cohorts. We could not analyze separately patients that fulfi lled the criteria for acute-on-chronic liver failure, as this term had not been introduced when this study was designed and data were captured ( 27 ) . Finally, we didn't consider the category of HCA infections, which was only recently introduced in hepatology practice ( 12 ) .
In conclusion, we demonstrated that infection most likely represents a distinct prognostic stage of cirrhosis, which aff ects survival irrespective of disease severity. Our fi ndings suggest that the occurrence of infection, even with recovery, should be regarded as a prognostic stage of cirrhosis beyond the decompensated stages and the term critically ill cirrhotic could be used for such patients. Future prospective studies should be directed at verifying the importance of this stage and evaluating parameters allowing the identifi cation of infected patients with an increased risk of worse outcome in the short term. From a more therapeutic point of view, studies addressing the primary and secondary prevention of infections other than SBP are needed to improve outcomes or to facilitate a smoother management toward liver transplantation.
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